EE53 The Net Monetary Benefit of Introducing Sodium-Glucose Cotransporter-2 Inhibitors in Middle-Income Countries
Abstract
Authors
M Falavigna O Deyneli A Seyam N Mustafa M Giorgi Z Gabriel S Goncalves J Solorzano H Vasnawala V Schabert J Mihajlović